Genovate Biotechnology (Taiwan) Performance
4130 Stock | TWD 21.80 0.10 0.46% |
Genovate Biotechnology has a performance score of 2 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.25, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Genovate Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genovate Biotechnology is expected to be smaller as well. Genovate Biotechnology right now retains a risk of 2.22%. Please check out Genovate Biotechnology downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Genovate Biotechnology will be following its current trending patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Genovate Biotechnology Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Genovate Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
Begin Period Cash Flow | 223.2 M | |
Total Cashflows From Investing Activities | 36.9 M | |
Free Cash Flow | -35.4 M |
Genovate |
Genovate Biotechnology Relative Risk vs. Return Landscape
If you would invest 2,115 in Genovate Biotechnology Co on December 27, 2024 and sell it today you would earn a total of 65.00 from holding Genovate Biotechnology Co or generate 3.07% return on investment over 90 days. Genovate Biotechnology Co is generating 0.0787% of daily returns and assumes 2.2235% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than Genovate, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Genovate Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genovate Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Genovate Biotechnology Co, and traders can use it to determine the average amount a Genovate Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0354
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | 4130 | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.22 actual daily | 19 81% of assets are more volatile |
Expected Return
0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Genovate Biotechnology is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genovate Biotechnology by adding it to a well-diversified portfolio.
Genovate Biotechnology Fundamentals Growth
Genovate Stock prices reflect investors' perceptions of the future prospects and financial health of Genovate Biotechnology, and Genovate Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genovate Stock performance.
Return On Equity | 0.0022 | |||
Return On Asset | 0.0015 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.01 % | |||
Current Valuation | 3.16 B | |||
Shares Outstanding | 109.38 M | |||
Price To Book | 2.62 X | |||
Price To Sales | 9.42 X | |||
Revenue | 434.25 M | |||
EBITDA | 39.64 M | |||
Book Value Per Share | 12.82 X | |||
Cash Flow From Operations | (17.26 M) | |||
Earnings Per Share | 0.03 X | |||
Total Asset | 1.52 B | |||
About Genovate Biotechnology Performance
Evaluating Genovate Biotechnology's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Genovate Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Genovate Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Genovate Biotechnology performance evaluation
Checking the ongoing alerts about Genovate Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Genovate Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Genovate Biotechnology generates negative cash flow from operations |
- Analyzing Genovate Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genovate Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Genovate Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genovate Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genovate Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genovate Biotechnology's stock. These opinions can provide insight into Genovate Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Genovate Stock Analysis
When running Genovate Biotechnology's price analysis, check to measure Genovate Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovate Biotechnology is operating at the current time. Most of Genovate Biotechnology's value examination focuses on studying past and present price action to predict the probability of Genovate Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovate Biotechnology's price. Additionally, you may evaluate how the addition of Genovate Biotechnology to your portfolios can decrease your overall portfolio volatility.